(Q46549441)

23 December 2017

title

Schizophrenia and amphetamine dependence. A case report (English)

1 reference

23 December 2017

1 reference

Dervaux A

1

1 reference

23 December 2017

Krebs MO

series ordinal

2

1 reference

23 December 2017

Laqueille X

series ordinal

3

1 reference

23 December 2017

publication date

1 March 2005

1 reference

23 December 2017

L'Encephale: revue de psychiatrie clinique biologique et therapeutique

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 December 2017

volume

31

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

247-250

1 reference

23 December 2017

A neurobiological basis for substance abuse comorbidity in schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Substance misuse among people with schizophrenia: similarities and differences between the UK and France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

When does amphetamine-induced psychosis become schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Amphetamine psychosis and psychotic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Provocative tests with psychostimulant drugs in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Development of psychiatric illness in drug abusers. Possible role of drug preference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Substance misuse, psychiatric disorder and violent and disturbed behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2805%2982391-7

10.1016/S0013-7006(05)82391-7

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017